Glenn Youngkin, Governor of the Commonwealth of Virginia, has called out North Carolina’s status as a top U.S. biomanufacturing hub — a competition he intends to win.
CEO Pascal Soriot announced the deal with President Trump on Friday, noting that it includes a three-year exemption from U.S. tariffs for AstraZeneca’s products.
The Switzerland-based injection system manufacturer will establish a new production facility in Holly Springs, North Carolina to strengthen its U.S. supply chain.
The CDMO is advancing construction of a large-scale buffer media facility at its Laupheim headquarters to expand biologics manufacturing capacity and automation.
